预测脓毒症相关急性肾损伤患者3个月死亡风险列线图的开发与验证
本研究基于美国重症监护医学信息数据库-IV(MIMIC-IV)2008至2021年脓毒症相关急性肾损伤(S-AKI)患者数据,以3个月全因死亡为结局,按7:3分为训练集与测试集。训练集经单因素Logistic回归、共线性分析、Lasso回归和随机森林算法筛选变量,最终将LODS、Charlson共病指数、尿量、INR、呼吸支持模式、血尿素氮和年龄7个变量纳入多因素Logistic回归模型并绘制列线图。测试集内部验证显示列线图AUC为0.81(95%CI 0.80-0.82),高于OASIS评分的0.70(95%CI 0.69-0.71),并显著高于SOFA评分的0.57(95%CI 0.56-0.58)和SIRS评分的0.56(95%CI 0.55-0.57);校准曲线和决策曲线分析显示列线图校准与临床净获益均优于上述三个评分。该模型为S-AKI患者预后评估提供了新工具。
要点
- 列线图纳入7个变量:LODS、Charlson共病指数、尿量、INR、呼吸支持模式、血尿素氮和年龄。
- 测试集内部验证列线图AUC为0.81(95%CI 0.80-0.82),高于OASIS评分的0.70(95%CI 0.69-0.71)。
- 列线图AUC显著高于SOFA评分的0.57(95%CI 0.56-0.58)和SIRS评分的0.56(95%CI 0.55-0.57)。
- 校准曲线显示列线图校准优于OASIS、SOFA和SIRS评分。
- 决策曲线分析提示列线图在不同概率阈值下临床净获益优于OASIS、SOFA和SIRS评分。
适用人群与场景
- 基于MIMIC-IV数据库2008至2021年脓毒症相关急性肾损伤(S-AKI)患者。
- 按诊断后3个月生存状态分为存活组7 768例(68.54%)和死亡组3 566例(31.46%)。
研究设计与关键结果
- 研究类型:基于MIMIC-IV数据库的预测模型开发与内部验证研究;数据按7:3分为训练集和测试集。
- 初始纳入58个相关预测因素,以3个月全因死亡为结局事件。
- 训练集经单因素Logistic回归初步筛选,再经共线性分析、Lasso回归和随机森林算法筛选变量,结合临床实用价值最终将7个变量纳入多因素Logistic回归模型并绘制列线图:LODS、Charlson共病指数、尿量、INR、呼吸支持模式、血尿素氮和年龄。
- 测试集内部验证:列线图AUC为0.81(95%CI 0.80-0.82),OASIS评分AUC为0.70(95%CI 0.69-0.71),SOFA评分AUC为0.57(95%CI 0.56-0.58),SIRS评分AUC为0.56(95%CI 0.55-0.57)。
- 校准曲线显示列线图校准优于OASIS、SOFA和SIRS评分。
- 决策曲线分析提示列线图在不同概率阈值下临床净获益优于OASIS、SOFA和SIRS评分。
证据类型、等级与局限
- 证据类型:基于MIMIC-IV数据库的预测模型开发与内部验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该列线图基于MIMIC-IV临床大数据和7个变量构建,具有良好的区分度和校准度,为评估S-AKI患者预后提供了有效的新工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop and evaluate a nomogram prediction model for the 3-month mortality risk of patients with sepsis-associated acute kidney injury (S-AKI).
METHODS: Based on the American Medical Information Mart for Intensive Care- IV (MIMIC- IV), clinical data of S-AKI patients from 2008 to 2021 were collected. Initially, 58 relevant predictive factors were included, with all-cause mortality within 3 months as the outcome event. The data were divided into training and testing sets at a 7 : 3 ratio. In the training set, univariate Logistic regression analysis was used for preliminary variable screening. Multicollinearity analysis, Lasso regression, and random forest algorithm were employed for variable selection, combined with the clinical application value of variables, to establish a multivariable Logistic regression model, visualized using a nomogram. In the testing set, the predictive value of the model was evaluated through internal validation. The receiver operator characteristic curve (ROC curve) was drawn, and the area under the curve (AUC) was calculated to evaluate the discrimination of nomogram model and Oxford acute severity of illness score (OASIS), sequential organ failure assessment (SOFA), and systemic inflammatory response syndrome score (SIRS). The calibration curve was used to evaluate the calibration, and decision curve analysis (DCA) was performed to assess the net benefit at different probability thresholds.
RESULTS: Based on the survival status at 3 months after diagnosis, patients were divided into 7 768 (68.54%) survivors and 3 566 (31.46%) death. In the training set, after multiple screenings, 7 variables were finally included in the nomogram model: Logistic organ dysfunction system (LODS), Charlson comorbidity index, urine output, international normalized ratio (INR), respiratory support mode, blood urea nitrogen, and age. Internal validation in the testing set showed that the AUC of nomogram model was 0.81 [95% confidence interval (95%CI) was 0.80-0.82], higher than the OASIS score's 0.70 (95%CI was 0.69-0.71) and significantly higher than the SOFA score's 0.57 (95%CI was 0.56-0.58) and SIRS score's 0.56 (95%CI was 0.55-0.57), indicating good discrimination. The calibration curve demonstrated that the nomogram model's calibration was better than the OASIS, SOFA, and SIRS scores. The DCA curve suggested that the nomogram model's clinical net benefit was better than the OASIS, SOFA, and SIRS scores at different probability thresholds.
CONCLUSIONS: A nomogram prediction model for the 3-month mortality risk of S-AKI patients, based on clinical big data from MIMIC- IV and including seven variables, demonstrates good discriminative ability and calibration, providing an effective new tool for assessing the prognosis of S-AKI patients.
参考来源
- Yue X, Li Z, Wang L, et al. [Development and validation of a nomogram for predicting 3-month mortality risk in patients with sepsis-associated acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38845491. doi:10.3760/cma.j.cn121430-20231218-01091
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。